Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: example from an Israeli healthcare worker cohortSARS-CoV-2 anti-S IgG 수준을 이전 감염의 지표로 사용: 이스라엘 의료 종사자 집단의 예Article Published on 2022-07-012022-09-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] anti-S anti-S IgG level anti-S IgG levels Antigen Chain Reaction Cohort COVID-19 Determining Epidemiology example healthcare worker IgG IgG level IgG levels Infection Israeli healthcare worker marker Negative predictive value polymerase chain polymerase chain reaction Predictive Predictive value public health SARS-CoV-2 SARS-COV-2 infection second dose Serological assay serology Testing threshold vaccination [DOI] 10.1016/j.ijid.2022.04.010 PMC 바로가기 [Article Type] Article
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients과거의 COVID-19 및 면역억제 요법은 간 이식 수혜자의 항 SARS-CoV-2 백신 접종에 대한 장기 반응에 영향을 미칩니다Article Published on 2022-07-012022-09-11 Journal: Journal of hepatology [Category] COVID19(2023년), MERS, SARS, 진단, 치료법, [키워드] Affect anti-RBD anti-receptor-binding domain anti-SARS-CoV-2 anti-SARS-CoV-2 vaccination anti-SARS-CoV-2 vaccine anti-SARS-CoV-2 vaccines Antibody Response Antibody titer ascites baseline BNT162b2 BNT162b2 vaccine Control controls COVID-19 COVID-19 recovered patient daily dose dose effective enrolled Frequency IgG IgG antibody immunogenicity immunosuppressive independent predictor independent predictors less leukocyte liver liver transplant Liver transplantation median MMF mRNA mRNA vaccine mycophenolate mycophenolate mofetil naïve negative controls negativity patients positive Protein recipient recipients regimen second vaccination serum significantly lower tested U/mL vaccination vaccine dose [DOI] 10.1016/j.jhep.2022.02.015 PMC 바로가기 [Article Type] Article
Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine콜히친 또는 하이드록시클로로퀸으로 정기적으로 치료받는 다양한 류마티스 질환 환자의 COVID-19 빈도 및 중증도Article Published on 2022-07-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 진단, 치료법, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus analyzed anti-SARS-CoV-2 IgG Arthritis being Clinical data Colchicine collected Contact control group coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19-related symptom COVID-19-related symptoms described disease Famial Mediterranean fever Familial Familial Mediterranean fever FIVE HCQ healthy hospital Hospital admission Hospitalized household contact Hydroxychloroquine IgG Immunoglobulin Immunoglobulin G less Lupus lupus erythematosus Manifestations Mediterranean fever Musculoskeletal nucleocapsid occurred Odds ratio Patient positive prevention of COVID-19 respiratory rheumatic and musculoskeletal disease. rheumatic disease Rheumatoid rheumatoid arthritis seropositive subjects serum sample serum samples severe disease severity of COVID-19 subject syndrome systemic systemic lupus erythematosus the patient treated Treatment [DOI] 10.1002/jmv.27731 PMC 바로가기 [Article Type] Article
SARS-CoV-2 active infection prevalence and seroprevalence in the adult population of St. Louis County세인트루이스 카운티 성인 인구의 SARS-CoV-2 활성 감염 유병률 및 혈청 유병률Article Published on 2022-07-012022-09-12 Journal: Annals of epidemiology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI absence black conducted COVID-19 COVID-19 infection estimate fatality Hospitalization IgG IgG antibodies Infection infection prevalence oversampling PCR Prevalence prevalence of COVID-19 probability survey random remained SARS-CoV-2 Seroprevalence Weighting were infected white widespread with COVID-19 [DOI] 10.1016/j.annepidem.2022.03.002 PMC 바로가기 [Article Type] Article
Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth임신 3기 전령 RNA COVID-19 부스터 백신 접종 시 산모 및 신생아 SARS-CoV-2 면역글로불린 G 항체 수준 급증Article Published on 2022-07-012022-09-12 Journal: European journal of obstetrics, gynecology, and re [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI 95% confidence interval Administered administration Admission analyzed antibodies antibody Antibody titers Blood BNT162b2 BNT162b2 mRNA body mass index booster booster dose booster vaccination Booster vaccine Characteristics contrary correlation COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine dropped evaluate IgG Immunoglobulin increase in Messenger RNA mRNA multivariable analysis Neonatal Newborn pandemic Pfizer/BioNTech Placenta positive correlation Pregnancy pregnant women prospective cohort study reflected response SARS-CoV-2 SARS-CoV-2 IgG antibody Side effect Standard deviation Support systemic side effect Third trimester. umbilical vaccination Vaccine vaccine dose were measured women [DOI] 10.1016/j.ejogrb.2022.05.029 PMC 바로가기 [Article Type] Article
Reduced SARS-CoV-2 disease outcomes in Syrian hamsters receiving immune sera: Quantitative image analysis in pathologic assessmentsArticle Published on 2022-07-012023-07-09 Journal: Veterinary pathology [Category] COVID19(2023년), [키워드] hamster IgG immunohistochemistry pathology quantitative image analysis SARS-CoV-2 technology [DOI] 10.1177/03009858221095794
Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?항체 반응의 역학은 중등도에서 중증의 COVID-19로 입원한 환자의 임상 결과를 예측합니까?Observational Study Published on 2022-07-012022-09-11 Journal: In vivo (Athens, Greece) [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody antibody kinetics Antibody Response Antibody responses association Chain Reaction clinical Clinical deterioration Clinical outcome clinical outcomes clinical risk factor Complication consecutive patient coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 disease COVID-19 infection COVID-19-related complication COVID-19-related complications diabetes diagnosed discharged dyslipidemia follow-up period Hospitalization Hospitalized hospitalized patient hospitalized patients hospitals IgG IgG positivity IgM Immunoglobulin Immunoglobulin G immunoglobulin M Infection intensive care unit Intubated Kinetics Logistic regression analysis males median median age median time moderate-to-severe COVID-19 observational study onset of symptoms Patient patients died polymerase chain polymerase chain reaction predict Predictive prospective observational study qualitative detection Rapid Rapid test respiratory response SARS-CoV-2 SARS-CoV-2 antibody Seroconversion serum severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severity symptomatic time interval time intervals Univariate logistic regression analysis was performed with COVID-19 [DOI] 10.21873/invivo.12916 PMC 바로가기 [Article Type] Observational Study
T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cellsSARS-CoV-2-특이적 T-세포 검출을 위한 T-세포 증식 분석Article Published on 2022-07-012022-09-11 Journal: Clinica chimica acta; international journal of cli [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법, 치료제, [키워드] an area Analysis antibody approved AUC B-cell B-cell response blood sample Blood samples carried cellular cellular immune responses clinical setting clinical settings complex Control control group controls ELISA assay False positive False positives Health care Health care worker health care workers humoral Humoral and cellular immune responses IgG immune immune responses Immunoglobulin Immunoglobulin G Infection less lymphocyte lymphocyte transformation Lymphocyte transformation test majority membrane N and M non-infected nucleocapsid peptide peptide pool peptide pools proliferation Protein representing resulting ROC analysis S protein S1 subunit SARS-CoV-2 SARS-CoV-2 spike protein Spike protein Stimulation T-cell T-cell Response T-cell responses the S protein the S1 subunit the SARS-CoV-2 thymidine Trigger vaccinated individual vaccination Vaccines were recorded [DOI] 10.1016/j.cca.2022.05.025 PMC 바로가기 [Article Type] Article
Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity원발성 쇼그렌 증후군에서 비활성화된 SARS-CoV-2 백신: 체액 반응, 안전성 및 질병 활동에 대한 영향Clinical Trial Published on 2022-07-012022-09-12 Journal: Clinical Rheumatology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 95% CI activity Adverse age anti-SARS-CoV-2 autoantibody Autoimmune disease booster dose comparable Control controls COVID-19 Deleterious detrimental Disease activity dose Effect event female Frequency geometric mean titer GMT humoral IgG immunogenicity index IQR Mild moderate Neutralizing activity neutralizing antibody participant Patient patients Point S1/S2 Safe Safety SARS-CoV-2 SARS-CoV-2 vaccine Seroconversion Sex Sjögren’s syndrome syndrome Trial Vaccine were assessed [DOI] 10.1007/s10067-022-06134-x PMC 바로가기 [Article Type] Clinical Trial
Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine나이와 비타민 D는 SARS-CoV-2 BNT162b2 백신의 첫 번째 접종에 대한 항체 반응의 크기에 영향을 미칩니다Article Published on 2022-07-012022-09-12 Journal: Current research in translational medicine [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abbott Diagnostics Affect affected age approved average baseline blood sample BNT162b2 BNT162b2 vaccine collected Concentration decrease dose Final first dose greater group HCW healthcare worker highest IgG immunization individual magnitude MOST of BNT162b2 Patient peak peak concentration peaked positive produced provided receive receiving remained response SARS-CoV-2 significant effect significantly spike Support the antibody response the SARS-CoV-2 UK Government Vaccine Vitamin Vitamin D Vitamin D status was measured was performed younger subject [DOI] 10.1016/j.retram.2022.103344 PMC 바로가기 [Article Type] Article